BLOG

Company News

Industry News

The innovative pharmaceutical market continues to expand, with capital increasingly favoring the Hong Kong Stock Connect healthcare sector.

The innovative pharmaceutical market continues to expand, with capital increasingly favoring the Hong Kong Stock Connect healthcare sector.

According to a report by the Qianzhan Industry Research Institute, China's innovative pharmaceutical market has experienced rapid growth, driven by favorable policies, dynamic adjustments in medical insurance, and increased R&D investments.

02

2023

/

03

Authorization for batch release of biological products expanded, accelerating product launch timelines.

Authorization for batch release of biological products expanded, accelerating product launch timelines.

To enhance the efficiency of batch release for biological products (vaccines), the National Medical Products Administration has decided, based on a thorough risk assessment, to gradually expand the scope—both in terms of provincial drug regulatory agencies authorized to conduct inspections and testing, and in the types of biological products (vaccines)—involved in the batch-release process.

02

2023

/

03

Multiple pharmaceutical companies jointly advance the development of immuno-oncology drugs.

Multiple pharmaceutical companies jointly advance the development of immuno-oncology drugs.

Several globally leading pharmaceutical companies have announced a collaboration to jointly advance the research and development of immuno-oncology drugs.

02

2023

/

03

Gene editing technology empowers rare disease drug development

Gene editing technology empowers rare disease drug development

As gene-editing technology continues to mature, its application in the development of drugs for rare diseases is steadily deepening.

02

2023

/

03

< 12 >